Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 410INDUSTRY 242NIH 41NETWORK 25OTHER_GOV 9UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Other solid neoplasm 1Genitourinary 1Breast 1

Conditions

Advanced Breast Cancer 1

Interventions

Paclitaxel 7Epirubicin 7Capecitabine 7pyrotinib 5Docetaxel 5Carboplatin 5Vinorelbine 4Fulvestrant 4Cyclophosphamide 4exemestane 3anlotinib 3Radiotherapy 3Radiation Dose Hypofractionation 3Etoposide 3pirarubicin 2palbociclib 2apatinib 2Standard of Care 2Neoadjuvant Therapy 2Letrozole 2Albumin-Bound Paclitaxel 2toripalimab 1titanium silicide 1nimotuzumab 1neratinib 1lobaplatin 1liposomal doxorubicin 1icaritin 1eribulin 1Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Trastuzumab × Breast × Clear all
NCT05020964 2021-08-25

Screening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and Pyrotinib

ChineseAMS

Phase 2 Unknown
68 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡